The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes

Immunity

Volumn 10, Issue 6, 1999, Pages 673-679

  Vonderheide, Robert H ^a   Hahn, William C ^a,b   Schultze, Joachim L ^a   Nadler, Lee M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE; TUMOR ANTIGEN;

ALLELE; AMINO ACID SEQUENCE; ANTIGEN BINDING; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; ENZYME ACTIVITY; ENZYME SUBUNIT; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION;

EID: 0033151591     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80066-7     Document Type: Article

References (35)

1. Bodnar, A.G., Ouellette, M., Frolkis, M., Holt, S.E., Chiu, C.-P., Morin, G.B., Harley, C.B., Shay, J.W., Lichtsteiner, S., and Wright, W.E. (1998). Extension of life-span by introduction of telomerase into normal human cells. Science 279, 349-352.
2. Bryan, T.M., Englezou, A., Dalla-Pozza, L., Dunham, M.A., and Reddel, R.R. (1997). Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat. Med. 3, 1271-1274.
3. Bystryn, J.-C., Henn, M., Li, J., and Shroba, S. (1992). Identification of immunogenic human melanoma antigens in a polyvalent melanoma vaccine. Cancer Res. 52, 5948-5953.
4. Counter, C.M., Avilion, A.A., LeFeuvre, C.E., Stewart, N.G., Greider, C.W., Harley, C.B., and Bacchetti, S. (1992). Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 11, 1921-1929.
5. Counter, C.M., Botelho, F.M., Wang, P., Harley, C.B., and Bacchetti, S. (1994). Stablization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes. J. Virol. 68, 3410-3414.
6. Counter, C.M., Hahn, W.C., Wei, W., Caddle, S.D., Beijersbergen, R.L., Lansdorp, P.M., Sedivy, J.M., and Weinberg, R.A. (1998a). Dissociation among in vitro telomerase activity, telomere maintenance and cellular immortalization. Proc. Natl. Acad. Sci. USA 95, 14723-14728.
7. Counter, C.M., Meyerson, M., Eaton, E.N., Ellisen, L.W., Caddle, S.D., Haber, D.A., and Weinberg, R.A. (1998b). Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase. Oncogene 16, 1217-1222.
8. Fujie, T., Tanaka, F., Mori, M., Takesako, K., Sugimachi, K., and Akiyoshi, T. (1997). Induction of antitumor cytotoxic T lymphocytes from the peripheral blood mononuclear cells of cancer patients using HLA-A2-restricted MAGE-3 peptide in vitro. Clin. Cancer Res. 3, 2425-2430.
9. Greider, C.W. (1995). Telomerase biochemistry and regulation. In Telomeres, E.H. Blackburn and C.W. Greider, eds. (Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press) pp. 35-68.
10. Harle-Bachor, C., and Boukamp, P. (1996). Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proc. Natl. Acad. Sci. USA 93, 6476-6481.
11. Harley, C.B., Futcher, A.B., and Greider, C.W. (1990). Telomeres shorten during ageing of human fibroblasts. Nature 345, 458-460.
12. Harrington, L., Zhou, W., McPhail, T., Oulton, R., Yeung, D.S., Mar, V., Bass, M.B., and Robinson, M.O. (1997). Human telomerase contains evolutionarily conserved catalytic and structural subunits. Genes Dev. 11, 3109-3115.
13. Hastie, N.D., Dempster, M., Dunlop, M.G., Thompson, A.M., Green, D.K., and Allshire, R.C. (1990). Telomere reduction in human colorectal carcinoma and with ageing. Nature 346, 866-868.
14. Klingelhutz, A.J., Barber, S.A., Smith, P.P., Dyer, K., and McDougall, J.K. (1994). Restoration of telomeres in human papillomavirus-immortalized human anogenital epithelial cells. Mol. Cell. Biol. 14, 961-969.
15. Klingelhutz, A.J., Foster, S.A., and McDougall, J.K. (1996). Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 380, 79-82.
16. Kim, N.W., and Wu, F. (1997). Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP). Nucleic Acids Res. 25, 2595-2597.
17. Kim, N.W., Piatyszek, M.A., Prowse, K.R., Harley, C.B., West, M.D., Ho, P.L.C., Coviello, G.M., Wright, W.E., Weinrich, S.L., and Shay, J.W. (1994). Specific association of human telomerase activity with immortal cells and cancer. Science 266, 2011-2013.
18. Kiyono, T., Foster, S.A., Koop, J.I., McDougall, J.K., Galloway, D.A., and Klingelhutz, A.J. (1998). Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 396, 84-88.
19. Kolquist, K.A., Ellisen, L.W., Counter, C.M., Meyerson, M., Tan, L.K., Weinberg, R.A., Haber, D.A., and Gerald, W.L. (1998). Expression of TERT in early premalignant lesions and a subset of cells in normal tissues. Nat. Genet. 19, 182-186.
20. Meyerson, M., Counter, C.M., Eaton, E.N., Ellisen, L.W., Steiner, P., Caddle, S.D., Ziaugra, L., Beijersbergen, R.L., Davidoff, M.J., Liu, Q., et al. (1997). hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90, 785-795.
21. Nakamura, T.M., Morin, G.B., Chapman, K.B., Weinrich, S.L., Andrews, W.H., Linger, J., Harley, C.B., and Cech, T.R. (1997). Telomerase catalytic subunit homologs from fission yeast and human. Science 277, 955-959.
22. Norrback, K.-F., and Roos, G. (1997). Telomeres and telomerase in normal and malignant haematopoietic cells. Eur. J. Cancer. 33, 774-780.
23. Prowse, K.R., and Greider, C.W. (1995). Developmental and tissue-specific regulation of mouse telomerase and telomere length. Proc. Natl. Acad. Sci. USA 92, 4818-4822.
24. Ramakrishnan, S., Eppenberger, U., Mueller, H., Shinkai, Y., and Narayanan, R. (1998). Expression profile of the putative catalytic subunit of the telomerase gene. Cancer Res. 58, 622-625.
25. Reynolds, S.R., Oratz, R., Sharpiro, R.L., Hao, P., Yun, Z., Fotino, M., Vukmanovic, S., and Bystryn, J.-C. (1997). Stimulation of CD8+ T cell responses to MAGE-3 and Melan A/Mart-1 by immunization to a polyvalent melanoma vaccine. Int. J. Cancer. 72, 972-976.
26. Rosenberg, S.A. (1997). Cancer vaccines based on the identification of genes encoding cancer regression antigens. Immunol. Today 18, 175-182.
27. Schultze, J.L., Michalak, S., Seamon, M.J., Dranoff, G., Jung, K., Daley, J., Delgado, J.C., Gribben, J.G., and Nadler, L.M. (1997). CD40-activated human B cells: An alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy. J. Clin. Invest. 100, 2757-2765.
28. Stoppler, H., Hartmann, D.P., Sherman, L., and Schlegel, R. (1997). The human papillomavirus type 16 E6 and E7 oncoproteins dissociate cellular telomerase activity from the maintenance of telomere length. J. Biol. Chem. 272, 13332-13337.
29. van der Bruggen, P., Bastin, J., Gajewski, T., Coulie, P.G., Boel, P., DeSmet, C., Traversari, C., Townsend, A., and Boon, T. (1994). A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Eur. J. Immunol. 24, 3038-3043.
30. Van den Eynde, B.J., and van der Bruggen, P. (1997). T cell defined tumor antigens. Curr. Opin. Immunol. 9, 684-693.
31. Van Pel, A., van der Bruggen, P., Coulie, P.G., Brichard, V.G., Lethe, B., van den Enynde, B., Uyttenhove, C., Renauld, J.C., and Boon, T. (1995). Genes coding for tumor antigens recognized by cytolytic T lymphocytes. Immunol. Rev. 145, 229-250.
32. Vaziri, H., and Benchimol, S. (1998). Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Current Biol. 8, 279-282.
33. Weinrich, S.L., Pruzan, R., Ma, L., Ouellette, M., Tesmer, V.M., Holt, S.E., Bodnar, A.G., Lichtsteiner, S., Kim, N.W., Trager, J.B., et al. (1997). Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat. Genet. 17, 498-502.
34. Weynants, P., Lethe, B., Brasseur, F., Marchand, M., and Boon, T. (1994). Expression of MAGE genes by non-small-cell lung carcinomas. Int. J. Cancer 56, 826-829.
35. Yasumoto, S., Kunimura, C., Kikuchi, K., Tahara, H., Ohji, H., Yamamoto, H., Ide, T., and Utakoji. T. (1996). Telomerase activity in normal human epithelial cells. Oncogene 13, 433-439.